PolyPid Ltd (NAS:PYPD)
$ 3.46 0 (0%) Market Cap: 23.54 Mil Enterprise Value: 25.22 Mil PE Ratio: 0 PB Ratio: 10.36 GF Score: 37/100

Q3 2023 PolyPid Ltd Earnings Call Transcript

Nov 08, 2023 / 01:30PM GMT
Release Date Price: $4.18 (-1.30%)
Brian Ritchie
LifeSci Advisors, LLC - IR

Thank you all for participating in PolyPid, third quarter 2023 earnings conference call. Joining me on the call today, will be Dikla Czaczkes Akselbrad, Chief Execuive Officer of PolyPid, Jonny Missulawin, PolyPid, Chief Financial Officer, and Ori Warshavsky, Chief Operating Officer of PolyPid.

Earlier today, PolyPid released financial results for the three and nine months ended September 30, 2023. A copy of the press release is available in the investors section on the company's website www.polypid.com.

I'd like to remind you that on this call, management will make forward-looking statements within the meeting of the Federal Securities Laws. For example, management is making forward-looking statements when it discusses recruitment of additional patients into SHIELD II, total recruitment time into the study and the timing of the top line results there from.

Its intention to conduct an unblinded interim analysis once a total of approximately 400 patients complete their 30

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot